date,title,source
Oct-31-18,Savara Completes Enrollment in Molgradex OPTIMA Clinical Study for the Treatment of NTM,GlobeNewswire
Nov-01-18,"Savara to Host Third Quarter 2018 Financial Results and Business Update Conference Call on November 7, 2018",GlobeNewswire
Nov-16-18,"Savara to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27th",GlobeNewswire
Dec-19-18,Savara Announces Interim Results for OPTIMA Clinical Study of Molgradex for the Treatment of NTM,GlobeNewswire
Jan-16-19,Could The Savara Inc. (NASDAQ:SVRA) Ownership Structure Tell Us Something Useful?,Simply Wall St.
Feb-06-19,Savara Provides Update on IMPALA and AVAIL Pivotal Clinical Studies,GlobeNewswire
Mar-04-19,Savara to Present at the 39th Annual Cowen and Company Healthcare Conference,ACCESSWIRE
Mar-06-19,"Savara To Report Q4/Year-End 2018 Financial Results And Business Update On March 13, 2019",ACCESSWIRE
Mar-12-19,Did Savara Inc. (NASDAQ:SVRA) Insiders Buy Up More Shares?,Simply Wall St.
Mar-13-19,Savara Inc. (SVRA) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-13-19,Savara Reports Fourth Quarter And Full Year 2018 Financial Results And Provides Business Update,ACCESSWIRE
Apr-01-19,Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection in People Living with Cystic Fibrosis,ACCESSWIRE
Apr-02-19,Savara to Present at the H.C. Wainwright Global Life Sciences Conference in London,ACCESSWIRE
Apr-09-19,Savara Inc (SVRA) Upgraded to Buy: Here's Why,Zacks
May-02-19,Savara to Report First Quarter 2019 Financial Results and Provide Business Update,Business Wire
May-06-19,Savara Announces Molgradex Received Fast Track Designation by FDA for Treatment of Autoimmune Pulmonary Alveolar Proteinosis,Business Wire
May-09-19,Savara Reports First Quarter 2019 Financial Results and Provides Business Update,Business Wire
May-15-19,Savara Inc (SVRA) Upgraded to Buy: Here's Why,Zacks
May-16-19,Savara Inc. (NASDAQ:SVRA) Is Expected To Breakeven,Simply Wall St.
May-17-19,Savara Inc. (SVRA) Q1 2019 Earnings Call Transcript,Motley Fool
Jun-10-19,Implied Volatility Surging for Savara (SVRA) Stock Options,Zacks
Jun-12-19,Savara Shares Slammed on Failed Phase 3 Drug Study,TheStreet.com
Jun-12-19,Savara stock plummets 75% after drug study fails to hit target,MarketWatch
Jun-12-19,"Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP)",Business Wire
Jun-13-19,Savara to Present at the JMP Securities Life Sciences Conference,Business Wire
Jun-13-19,Savara Plunges After Lung Disease Drug Fails Phase 3 Trial,TheStreet.com
Jun-13-19,Here's Why Savara Pharmaceuticals Collapsed Today,Motley Fool
Jun-13-19,Savara Plunges on Failure of Late-Stage Study on Molgradex,Zacks
Jun-19-19,"Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data",Zacks
